PHILIP RUZBARSKY: Open Payments
NPI 1225097058 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,958 in 102 payments from 22 companies in 2025. Trend: 2023 $3,145 · 2024 $2,429 · 2025 $1,958
Food & beverage: $1,958
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $340 |
| ABBVIE INC. | 22 | $303 |
| Lundbeck LLC | 9 | $202 |
| Novo Nordisk Inc | 8 | $154 |
| PFIZER INC. | 6 | $125 |
| Lilly USA, LLC | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Exact Sciences Corporation | 4 | $99 |
| Orexo US, Inc. | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
Products named: Sunosi, Auvelity, VRAYLAR, VYEPTI, NURTEC ODT, CAPLYTA, Zubsolv, REXULTI.
Industry payments across MD — which companies pay providers there.
